一个定制的移动应用程序与当地美食数据库为2型糖尿病的自我管理:随机对照试验
Supasuta Wongdama1, Wannaporn Paemueang1, Chutintorn Sriphrapradang1
1Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchatewi, Bangkok, 10400, Thailand, 66 22011647.
JMIR diabetes
|December 29, 2025
概括
一个用于糖尿病自我管理的移动应用程序在改善2型糖尿病患者的血糖控制方面取得了适度的成功. 该应用程序在年轻成年人中显著降低了禁食血葡萄糖,这表明了定制数字健康工具的潜力.
科学领域:
- 数字健康数字健康
- 糖尿病管理 糖尿病管理
- 移动卫生干预行动 移动卫生干预行动
背景情况:
- 现有的糖尿病自我管理移动应用程序往往忽视了西方人口的需求.
- 目前的移动糖尿病应用程序中缺乏与亚洲环境相关的饮食内容.
- 本研究介绍了一个移动应用程序,旨在填补这一缺口,提供特定区域的饮食信息和自我护理工具.
研究的目的:
- 评估移动应用程序在增强血糖控制和自我护理行为方面的有效性.
- 评估该应用程序对门诊患者的影响,这些患者患有无控的2型糖尿病.
- 为了确定应用程序是否与标准护理相比改善了结果.
主要方法:
- 一项随机对照试验对129名患有2型糖尿病和HbA1c>7%的成年人进行.
- 参与者使用了Rama糖尿病护理应用程序 (干预组) 或接受标准护理 (对照组) 6个月.
- 该应用程序具有营养记录与区域食品数据库,葡萄糖监测和生活方式跟踪.
主要成果:
- 与对照组相比,干预组显示HbA1c没有显著降低 (-0.24%,P=.13).
- 在65岁以下的参与者中,干预组的禁食血葡萄糖 (FPG) 显着较低 (平均差异为-29.3 mg/dL;P=.03).
- 用户对应用的整体满意度被评为中等.
结论:
- 移动应用程序显示了可比标准护理的血糖控制.
- 在年轻的参与者 (<65岁) 中观察到显著的FPG改善.
- 针对地区的定制移动应用程序对2型糖尿病自我管理有希望,需要进一步调查.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Management and Pharmacotherapy
844
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
844
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
559
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
559


